-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GH23AE/T8Iv34X3CLM8WtODvMxeE8RQqHXVJh4KW2mYL13lrQfp6v1/KrCWP3JjN XiZO1MFIONS0CpIwpEeONA== 0001250853-09-000049.txt : 20090706 0001250853-09-000049.hdr.sgml : 20090703 20090706135956 ACCESSION NUMBER: 0001250853-09-000049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090701 FILED AS OF DATE: 20090706 DATE AS OF CHANGE: 20090706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wieland Douglas Scott CENTRAL INDEX KEY: 0001450614 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15327 FILM NUMBER: 09930293 MAIL ADDRESS: STREET 1: 26826 SALINAS LANE CITY: MISSION VIEHO STATE: CA ZIP: 92691 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTRX CORP CENTRAL INDEX KEY: 0000799698 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581642750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 BUSINESS PHONE: 310-826-5648 MAIL ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-07-01 0 0000799698 CYTRX CORP CYTR 0001450614 Wieland Douglas Scott 11726 SAN VICENTE BLVD, #653 LOS ANGELES CA 90049 0 1 0 0 Sr. VP - Drug Development Stock Option (right to buy) 4.08 2009-07-01 4 D 0 100000 D 2017-05-22 Common Stock 100000 0 D Stock Option (right to buy) 1.15 2009-07-01 4 A 0 100000 A 2017-05-22 Common Stock 100000 100000 D Stock Option (right to buy) 3.61 2009-07-01 4 D 0 25000 D 2017-12-04 Common Stock 25000 0 D Stock Option (right to buy) 1.15 2009-07-01 4 A 0 25000 A 2017-12-04 Common Stock 25000 25000 D The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 30, 2007 and provided for vesting in three equal annual installments beginning May 30, 2008. The replacement option provides vesting two-thirds of the option on December 31, 2009, and vesting one-third of the option on May 30, 2010, providing the Reporting Person remains in continuous employ of Issuer. The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 6, 2007 and provided for vesting in three equal annual installments beginning December 6, 2008. The replacement option provides vesting one-third of the option on December 31, 2009, vesting one-third on December 6, 2010, and vesting one-third on December 6, 2011, provided Reporting Person remains in continuous employ of Issuer. /s/ D. Scott Wieland 2009-07-06 -----END PRIVACY-ENHANCED MESSAGE-----